The current study has demonstrated that EPA significantly inhibited the VEGF-stimulated activation of proinflammatory cytokines and chemokines in the vascular endothelial cells and provides new insights into the roles of EPA in the pathophysiology of vascular inflammation and atherosclerosis. The gene discussed is VEGFA; the disease is inflammatory response.